Biologics Utilization Impacting US Health Care Spending

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, and Chad Cannon, PharmD, BCCCP, open a panel discussion highlighting specialty biologics and navigating challenges for biosimilar uptake.

Now Viewing

EP: 1.Biologics Utilization Impacting US Health Care Spending

EP: 2.Current Landscape of Biosimilar Use in US Health Care Space

Video content above is prompted by the following:

How significant is the impact of specialty medications, particularly biologics, on current US health care spending?
What have been the major challenges and successes in reducing health care costs through the use of biosimilars?
- Briefly, what is hindering biosimilar uptake?
- Where have biosimilars been successful?
What are some strategies for successful biosimilar adoption?